SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/C48E0059A815E1101D8828DBA19DA01E97D7E460191B2AF71229F9769670AA617FFAF43D951833EB1BA99F5F3D50C883>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/C48E0059A815E1101D8828DBA19DA01E97D7E460191B2AF71229F9769670AA617FFAF43D951833EB1BA99F5F3D50C883
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/C48E0059A815E1101D8828DBA19DA01E97D7E460191B2AF71229F9769670AA617FFAF43D951833EB1BA99F5F3D50C883
http://www.w3.org/2000/01/rdf-schema#comment
"The most common point mutations detected and associated with drug resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia were T3151 and M244V."
xsd:string
http://purl.uniprot.org/uniprot/#_10C0FCD933407FEB5C8DE3A37E1CAF38F58768CF35F9FD08D9DF8AD1CB8238BCF6CBE15FBD250FC7079F4E1DFC9A19C4
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/C48E0059A815E1101D8828DBA19DA01E97D7E460191B2AF71229F9769670AA617FFAF43D951833EB1BA99F5F3D50C883
http://purl.uniprot.org/uniprot/Q13688
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C48E0059A815E1101D8828DBA19DA01E97D7E460191B2AF71229F9769670AA617FFAF43D951833EB1BA99F5F3D50C883
http://purl.uniprot.org/uniprot/#_Q13688-mappedCitation-21591355
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/C48E0059A815E1101D8828DBA19DA01E97D7E460191B2AF71229F9769670AA617FFAF43D951833EB1BA99F5F3D50C883